We are live on ! Find out more
AL

Aspiriant LLC Portfolio holdings

AUM $3.51B
1-Year Est. Return 13.98%
This Fund
S&P 500
This Quarter Est. Return
+5.82%
1 Year Est. Return
+13.98%
3 Year Est. Return
+39.43%
5 Year Est. Return
+43.32%
10 Year Est. Return
+133.07%
AUM
$1.08B
AUM Growth
-$35.7M
Cap. Flow
-$77.1M
Cap. Flow %
-7.14%
Top 10 Hldgs %
56.03%
Holding
217
New
10
Increased
48
Reduced
101
Closed
16

Sector Composition

Rank Sector Weight
1 Technology 4.29%
2 Financials 4%
3 Communication Services 2.41%
4 Healthcare 1.51%
5 Consumer Discretionary 0.84%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
QEMM icon
76
State Street SPDR MSCI Emerging Markets StrategicFactors ETF
QEMM
$53.4M
$1.29M 0.12%
21,293
TOTL icon
77
State Street DoubleLine Total Return Tactical ETF
TOTL
$4.15B
$1.28M 0.12%
26,210
-2,671
-9% -$131K
DOCU
78
DocuSign
DOCU
$10.1B
$1.24M 0.11%
16,739
IWN icon
79
iShares Russell 2000 Value ETF
IWN
$14.4B
$1.22M 0.11%
9,453
+1,961
+26% +$242K
MRK icon
80
Merck
MRK
$315B
$1.2M 0.11%
13,813
-478
-3% -$39.3K
MMM icon
81
3M
MMM
$83.4B
$1.2M 0.11%
8,132
-2,224
-21% -$311K
MA icon
82
Mastercard
MA
$480B
$1.19M 0.11%
3,997
-160
-4% -$45.1K
MDY icon
83
State Street SPDR S&P MIDCAP 400 ETF Trust
MDY
$27.3B
$1.17M 0.11%
3,118
CWB icon
84
State Street SPDR Bloomberg Convertible Securities ETF
CWB
$5.78B
$1.17M 0.11%
21,052
VTV icon
85
Vanguard Value ETF
VTV
$186B
$1.16M 0.11%
9,707
+610
+7% +$70.4K
HYG icon
86
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
$16.9B
$1.16M 0.11%
13,205
+443
+3% +$38.6K
VV icon
87
Vanguard Large-Cap ETF
VV
$52.2B
$1.15M 0.11%
7,787
-20,425
-72% -$2.89M
SCHV
88
Schwab US Large-Cap Value ETF
SCHV
$15.5B
$1.13M 0.1%
56,292
+19,161
+52% +$371K
IJR icon
89
iShares Core S&P Small-Cap ETF
IJR
$110B
$1.13M 0.1%
13,430
-287
-2% -$23.1K
INTC icon
90
Intel
INTC
$478B
$1.11M 0.1%
18,541
-145
-0.8% -$8.11K
CSCO icon
91
Cisco
CSCO
$441B
$1.08M 0.1%
22,551
+30
+0.1% +$1.39K
KO icon
92
Coca-Cola
KO
$351B
$1.06M 0.1%
19,196
-503
-3% -$27K
RSP icon
93
Invesco S&P 500 Equal Weight ETF
RSP
$96B
$1.05M 0.1%
9,090
-138
-1% -$15.3K
XOM icon
94
ExxonMobil
XOM
$611B
$1.03M 0.1%
14,747
-828
-5% -$57.3K
PFE icon
95
Pfizer
PFE
$143B
$1.01M 0.09%
27,167
-100
-0.4% -$3.56K
SCHH icon
96
Schwab US REIT ETF
SCHH
$11.6B
$1M 0.09%
43,676
-2,136
-5% -$49.8K
LOW icon
97
Lowe's Companies
LOW
$117B
$985K 0.09%
8,210
-290
-3% -$33.2K
GWX icon
98
State Street SPDR S&P International Small Cap ETF
GWX
$856M
$978K 0.09%
30,727
-162
-0.5% -$5K
PAYX icon
99
Paychex
PAYX
$40.7B
$966K 0.09%
11,373
-240
-2% -$20.2K
QUAL icon
100
iShares MSCI USA Quality Factor ETF
QUAL
$46.1B
$951K 0.09%
9,423
+2,308
+32% +$222K

Similar funds

Aspiriant LLC's Q4 2019 Portfolio in Review

As of Q4 2019, Aspiriant LLC held 217 positions worth $1.08B, down 3.2% from $1.12B the previous quarter. Its ten largest holdings account for 56% of the portfolio.

Aspiriant LLC withdrew a net $77.1M in Q4 2019, closing 16 positions and reducing 101 holdings. Its most notable exit was UBS E-TRACS Alerian MLP Infrastructure ETN, an estimated $19.5M position sold in full.

By sector, the portfolio is most concentrated in Technology at 4.3% of assets, up from 3.5% a quarter earlier, followed by Financials and Communication Services.

Against the trend, Aspiriant LLC opened a new position in Fifth Third Bancorp worth $1.68M.

  • Aspiriant LLC's largest Q4 2019 buy was Fifth Third Bancorp: 54,623 shares worth $1.68M.
  • Aspiriant LLC added most to Vanguard Small-Cap Value ETF in Q4 2019, an estimated $14.1M increase.
  • Aspiriant LLC's biggest Q4 2019 reduction was iShares MSCI USA Min Vol Factor ETF, cutting an estimated $14M.
  • Aspiriant LLC fully exited UBS E-TRACS Alerian MLP Infrastructure ETN in Q4 2019, selling an estimated $19.5M.
  • Aspiriant LLC's ten largest holdings make up 56% of its $1.08B portfolio in Q4 2019.
  • Aspiriant LLC opened 10 new positions and closed 16 in Q4 2019.
  • Aspiriant LLC's portfolio value fell 3.2% quarter-over-quarter to $1.08B.

Based on Aspiriant LLC's 13F filing for Q4 2019, filed 27 Jan 2020.